References
- Engström A. Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis. Infect Dis (Lond). 2016;48:1–17.
- Almog R, Mannella CA. Molecular packing of cord factor and its interaction with phosphatidylinositol in mixed monolayers. Biophys J. 1996;71:3311–3319.
- Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov. 2013;12:388–404.
- Diederen BM, van Duijn I, Willemse P, et al. In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains. Antimicrob Agents Chemother. 2006;50:3189–191.
- Fernández Guerrero ML, Robles I, Nogales Mdel C, et al. Corynebacterium striatum: an emerging nosocomial drug-resistant endocardial pathogen. J Heart Valve Dis. 2013;22:428–30.
- Silverman JA, Mortin LI, Vanpraagh AD, et al. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis. 2005;191:2149–2152.
- Bastian S, Brossier F, Wichlacz C, et al. Daptomycin is not active against rapidly growing mycobacteria. J Med Microbiol. 2010;59:135–136.
- Le Chevalier F, Cascioferro A, Majlessi L, et al. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development. Future Microbiol. 2014;9:969–985.
- Choo SW, Wee WY, Ngeow YF, et al. Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential. Sci Rep. 2014;4:4061.
- López-Marín LM, Segura E, Hermida-Escobedo C, et al. 6,6'-Dimycoloyl trehalose from a rapidly growing Mycobacterium: an alternative antigen for tuberculosis serodiagnosis. FEMS Immunol Med Microbiol. 2003;36:47–54.
- Oh CT, Moon C, Park OK, et al. Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model. J Antimicrob Chemother. 2014;69:1599–1607.
- Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:2538–2544.